The Column Group II, LP 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 8:20 pm Sale | 2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT | The Column Group II, LP | 200,449 4.900% | -352,731 (-63.76%) | Filing |
| 2023-01-13 4:50 pm Purchase | 2022-05-10 | 13D | RAPT Therapeutics, Inc. RAPT | The Column Group II, LP | 553,180 13.100% | 158,651 (+40.21%) | Filing |
| 2021-09-20 5:18 pm Sale | 2021-09-10 | 13D | RAPT Therapeutics, Inc. RAPT | The Column Group II, LP | 394,529 10.700% | -150,127 (-27.56%) | Filing |
| 2021-08-30 5:21 pm Sale | 2021-08-18 | 13D | RAPT Therapeutics, Inc. RAPT | The Column Group II, LP | 544,656 14.800% | -161,969 (-22.92%) | Filing |